论文部分内容阅读
目的探讨依达拉奉联合长春西汀治疗急性脑梗死患者的临床疗效。方法将78例急性脑梗死患者随机分为治疗组40例和对照组38例,观察两组患者经治疗后的神经功能恢复情况。结果两组患者在用药7d和21d后神经功能缺损评分,与治疗前有着显著差异(P<0.05),与对照组比较,治疗组患者神经功能恢复较早,且缺损分值减少幅度明显,组间差异有统计学意义(P<0.01)。结论依达拉奉联合长春西汀治疗急性脑梗死临床疗效显著,明显改善神经功能缺损,且安全性高,值得临床推广。
Objective To investigate the clinical efficacy of edaravone and vinpocetine in patients with acute cerebral infarction. Methods A total of 78 patients with acute cerebral infarction were randomly divided into treatment group (40 cases) and control group (38 cases). The recovery of neurological function after treatment in both groups was observed. Results Compared with the control group, the neurological deficit scores of the two groups were significantly different from those before treatment (P <0.05) after 7 and 21 days of treatment, and the recovery of neurological function of the treatment group was earlier and the deficit score decreased significantly The difference was statistically significant (P <0.01). Conclusion Edaravone combined with vinpocetine in the treatment of acute cerebral infarction has significant clinical curative effect, significantly improved neurological deficit, high safety and worthy of clinical promotion.